Moshirfar Majid, Mirzaian Garen, Feiz Vahid, Kang Paul C
John A. Moran Eye Center, Department of Ophthalmology, University of Utah, Salt Lake City, Utah 84132, USA.
J Cataract Refract Surg. 2006 Mar;32(3):515-8. doi: 10.1016/j.jcrs.2005.12.108.
We report the first 2 cases of bacterial keratitis resistant to fourth-generation fluoroquinolones after laser in situ keratomileusis (LASIK) and photorefractive keratectomy (PRK). The first patient had Pseudomonas aeruginosa keratitis after PRK despite treatment with moxifloxacin. The second patient was on gatifloxacin post-LASIK when she had methicillin-resistant Staphylococcus aureus (MRSA) keratitis diagnosed. In both cases, culture susceptibilities showed isolates resistant to moxifloxacin and gatifloxacin, and treatment with topical aminoglycosides and surgical intervention was necessary to effect a cure. These cases show the potential limitations in the coverage of these antibiotics.
我们报告了首例2例在准分子原位角膜磨镶术(LASIK)和准分子激光角膜切削术(PRK)后对第四代氟喹诺酮类药物耐药的细菌性角膜炎病例。首例患者在接受PRK术后,尽管使用莫西沙星治疗,仍发生了铜绿假单胞菌角膜炎。第二例患者在LASIK术后使用加替沙星时,被诊断为耐甲氧西林金黄色葡萄球菌(MRSA)角膜炎。在这两例病例中,培养药敏结果显示分离菌株对莫西沙星和加替沙星耐药,因此需要局部使用氨基糖苷类药物治疗并进行手术干预才能治愈。这些病例显示了这些抗生素覆盖范围的潜在局限性。